CBD-infused Products Market (2025-2032)
The CBD-infused Products Market was valued at $32.22 billion in 2024. This market is expected to reach $291.39 billion by 2032 from an estimated $44.94 billion in 2025, at a CAGR of 30.6% during the forecast period from 2025 to 2032. CBD-infused Products Market Size & Forecast The growth of this market
- Published
- Mar 2025
- Pages
- 210
- Format
- PDF + Excel
- Report ID
- MRFB - 104490
- Base year
- 2024
- 2024 · BASELINE
- $32.22B
- 2032
- $291.4B
- CAGR 2025–2032
- 30.6%
2024 baseline · 2025–2032 forecast at 30.6% CAGR · hover a bar for the value
Key highlights
The CBD-infused Products Market was valued at $32.22 billion in 2024.
This market is expected to reach $291.39 billion by 2032 from an estimated $44.94 billion in 2025, at a CAGR of 30.6% during the forecast period from 2025 to 2032.
The Hemp Segment to Dominate the CBD-infused Products Market in 2025
The Offline Stores Segment to Dominate the CBD-infused Products Market in 2025
In 2025, North America is expected to account for the largest share of 59.5% of the CBD-infused Products market, followed by Europe and Asia-Pacific.
Report summary
| Particulars | Details |
|---|---|
| Number of Pages | 210 |
| Format | |
| Forecast Period | 2025–2032 |
| Base Year | 2024 |
| CAGR (Value) | 30.6% |
| Market Size (Value) | USD 291.39 Billion by 2032 |
| Segments Covered | By Source · Hemp · Marijuana · By Type · Edibles · Confectionery Products · Bakery Products · Beverages · Coffee & Tea Products · Other Edible Products · Oil & Extracts · Personal Care Products · Skincare Products · Oil · Creams & Moisturizers · Masks & Serums · Other Skincare Products · Haircare Products · Deodorants and Perfumes · Other Personal Care Products · Smoke & Vape Products · Supplements · Other CBD Products · By Distribution Channel · Offline Stores · Dispensary · Pharmacies · Natural Health Foods Store · Other Stores · Online Store |
| Countries Covered | North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Australia, New Zealand, China, India, Japan, South Korea, and Rest of Asia-Pacific), Latin America (Mexico, Brazil, Colombia, Argentina, Uruguay, and Rest of Latin America), and the Middle East & Africa (Israel, South Africa, and the rest of Middle East & Africa). |
| Key Companies | Canopy Growth Corporation (Canada), Aurora Cannabis Inc. (Canada), Maricann Inc. (Canada), Tilray Brands, Inc. (Canada), GW Pharmaceuticals plc (U.K.), MediPharm Labs Corp. (Canada), Cresco Labs Inc. (U.S.), Tauriga Sciences, Inc. (U.S.), MariMed Inc. (U.S.), CV Sciences, Inc. (U.S.), Kona Gold Beverage, Inc. (U.S.), Bhang Inc. (U.S.), DT Brands & Co (N.I.) Ltd. (U.S.), Irwin Naturals Inc. (U.S.), Hempstrol Pharma (India), Kapu Maku LLC. (U.S.), Medterra CBD, LLC. (U.S.), Endoca LLC (U.S.), and Elixinol Global Limited (Australia). |
Report overview
Segments covered: source, type, distribution channel. Regions: North America, Europe, Asia-Pacific, Latin America.
The growth of this market is driven by the growing demand for cannabis, the increasing legalization of cannabis across various jurisdictions, and the rising popularity of cannabis-infused edibles. Additionally, the medicinal and therapeutic health benefits associated with cannabis-infused products further contribute to this upward trend. However, the high costs associated with cannabidiol (CBD) and stringent government regulations on cannabis in certain countries are anticipated to restrain the growth of this market.
Moreover, the increasing demand for cannabis in pet food, along with the rising popularity of cannabis-infused beverages, is expected to generate significant growth opportunities for market players. However, health risks related to the overconsumption of CBD pose a significant challenge in the market.
Report infographic
Market dynamics
4 factors across 2 forcesRising Demand and Increasing Legalization of Cannabis
Over the past two decades, substantial advancements have been made in the legalization and regulation of cannabis for both medical and recreational use globally. This shift has created a favorable legal environment that has significantly boosted demand for cannabis-infused products, especially those containing CBD (cannabidiol).
Cannabis remains the most widely cultivated, trafficked, and abused illicit drug worldwide. However, its acceptance for recreational and medicinal use has been steadily increasing. In 2018, Canada legalized cannabis for both purposes, and as of February 2025, 24 states, the District of Columbia, and two territories (Guam and the Northern Mariana Islands) permitted cannabis use for non-medical adult purposes. Legislative actions, ballot measures, and public opinion reflect this shift. A 2025 Pew Research Center survey indicates that 88% of U.S. adults believe marijuana should be legal for medical or recreational use, with 32% supporting legalization solely for medical purposes and 57% favoring legalization for both medical and recreational use.
As legalization expands both domestically and internationally, the market for CBD-infused products is projected to experience significant growth. The legal status of cannabis allows businesses to operate with greater freedom, promoting innovation and increasing product availability, which in turn drives consumer interest and demand for CBD products. Furthermore, the growing market highlights the need for robust regulations on cannabidiol (CBD) to enhance consumer safety.
Medicinal and Therapeutic Health Benefits Offered by Cannabis-infused Products
The medicinal use of cannabis is legal in certain countries, where marijuana is used primarily for stress and pain relief, as well as to stimulate appetite. Cannabidiol (CBD) is one of the key compounds found in the cannabis plant, known for its medicinal and therapeutic benefits without the psychoactive effects typically associated with marijuana.
The global surge in demand for CBD oil is primarily attributed to its potential to alleviate various ailments. CBD oil is recognized for its anti-inflammatory properties and its effectiveness in managing certain behavioral symptoms of Alzheimer's disease. Additionally, It is also utilized in managing the symptoms of epilepsy, anxiety, chronic pain, neuroprotection, anti-acne applications, cancer treatments, and mental health disorders.
Furthermore, an increasing number of spas are incorporating exclusive CBD-infused massages into their treatment offerings, enhancing the concept of holistic relaxation. These massages utilize CBD-infused topicals—such as lotions, balms, oils, and creams—allowing the compound to enter the bloodstream directly, resulting in immediate effects without the need for digestion.
As a result, the growing adoption of CBD for various health concerns is expected to raise awareness of cannabis applications, thereby driving the expansion of the CBD-infused products market.
Table of contents
11 chapters · 134 sections · 210 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Source | Hemp | — |
| By Distribution Channel | Offline Stores | Online store |
By Source
- The Hemp Segment to Dominate the CBD-infused Products Market in 2025
- The hemp segment is expected to account for a larger share of 76.3% of the CBD-infused products market.
- This large market share is attributed to the growing demand for hemp-sourced CBD-infused products, primarily due to their lower THC concentrations, which reduce or eliminate psychoactive effects and make them more suitable for various medical applications.
- In addition, the anti-inflammatory, anti-aging, and antioxidant properties of CBD derived from hemp contribute significantly to the segment’s significant share.
- Furthermore, the hemp segment is estimated to register a higher CAGR of 32.7% during the forecast period.
- This growth is driven by hemp’s expanding applications in personal care products, including cosmetics and skincare.
- Increasing consumer awareness and innovative uses in health and wellness are expected to further boost the growth of this market.
By Distribution Channel
- The Offline Stores Segment to Dominate the CBD-infused Products Market in 2025
- The offline stores segment is expected to account for a larger share of the CBD-infused products market.
- This segment's large market share is primarily driven by consumers' perception of obtaining authentic, high-quality products, the enhanced shopping experience provided by these channels, and the preference for in-person shopping experiences.
- However, the online store segment is estimated to register the highest CAGR during the forecast period.
- This growth is fueled by consumers' increasing preference for online shopping, the convenience provided by digital platforms, and the availability of greater discounts compared to physical stores.
- Additionally, the rising demand for personalized experiences and the rapid expansion of CBD-infused products on e-commerce platforms are contributing factors.
Geographic analysis
North America
Largest shareIn 2025, North America is expected to account for the largest share of 59.5% of the CBD-infused Products market, followed by Europe and Asia-Pacific. North America's CBD-infused products market is estimated to be worth USD 26.76 billion in 2025. North America's large market share is attributed to several key factors, including easy accessibility, technological advancements in the production and processing of CBD-infused products, and a large consumer base. Changing perceptions of CBD consumption for both medical and recreational purposes, increasing awareness of its various medical benefits, and rising consumer spending on CBD-infused products also contribute to this large market share. Furthermore, this region is estimated to register the highest CAGR of 34.3% during the forecast period. This growth is driven by rising health and wellness trends, increased R&D expenditures on CBD, growing investments from leading companies, and the expansion of online shopping. North America Dominates the CBD-infused Products Market
Competitive landscape
- December 2023
Rare Cannabinoid Company (U.S.) launched THC+THV uplift gummies, featuring a unique blend of cannabinoids aimed at delivering uplifting effects and appetite control.
- May 2022
Curaleaf Holdings, Inc. (U.S.) introduced the Select CBD Bites product range under the Select CBD brand, addressing the increasing consumer demand for convenient and effective CBD-infused edibles.
- April 2021
Canopy Growth Corporation (Canada) partnered with Southern Glazer’s Wine & Spirits to launch Quatreau, Canopy’s first line of CBD-infused beverages in the U.S. market.
- Aurora Cannabis Inc. · Canada
- Maricann Inc. · Canada
- Tilray Brands, Inc. · Canada
- GW Pharmaceuticals plc (U.K.)
- MediPharm Labs Corp. · Canada
- Cresco Labs, Inc. (U.S.)
- Tauriga Sciences, Inc. (U.S.)
- MariMed Inc. (U.S.)
- CV Sciences, Inc. (U.S.)
- Kona Gold Beverage, Inc. (U.S.)
- Bhang Inc. (U.S.)
- DT Brands & Co (N.I.) Ltd. (U.S.)
- Irwin Naturals Inc. (U.S.)
- Hempstrol Pharma · India
- Kapu Maku LLC. (U.S.)
- Medterra CBD, LLC. (U.S.)
- Endoca LLC (U.S.)
- Elixinol Global Limited · Australia
Frequently asked questions
The CBD-infused products market study provides valuable insights, market sizes, and forecasts in terms of value by source, type, distribution channel, and geography.
Cite this report
Meticulous Research. (2025). CBD-infused Products Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRFB - 104490). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/cbd-infused-products-market-5184